Our Core Services
Human Biospecimen Collection: MT Group’s Expert Solutions in 2025
Discover how MT Group delivers high-quality human biospecimen collection with comprehensive clinical metadata for oncology and autoimmune research.
Introduction
Human biospecimen collection is the cornerstone of translational research, providing high-quality biological samples like tissue, blood, and biofluids to drive breakthroughs in oncology, autoimmune diseases, and infectious diseases. These samples, paired with comprehensive clinical metadata, enable researchers to develop novel therapeutics and diagnostics. MT Group, a Los Angeles-based Contract Research Organization (CRO) established in 2003, excels in human biospecimen collection, offering tailored solutions for researchers. This 2025 guide explores why MT Group is a trusted partner for advancing research.
Whether you’re studying cancer biomarkers or autoimmune mechanisms, MT Group’s expertise ensures reliable, ethically sourced biospecimens. Let’s dive into the importance of human biospecimen collection and how MT Group leads the way.
Importance of Human Biospecimen Collection
Human biospecimen collection involves acquiring biological materials—such as tissue, blood, and biofluids—for research, ensuring ethical sourcing and detailed clinical data. These samples are vital for advancing biomedical research, as highlighted by the National Cancer Institute, which notes their role in precision medicine and biomarker discovery.
- Precision Medicine: Tumor tissues and blood samples fuel initiatives like The Cancer Genome Atlas (TCGA), enabling personalized therapies.
- Biomarker Discovery: Liquid biopsies from plasma detect circulating tumor cells for early diagnosis.
- Reproducibility: Comprehensive clinical metadata ensures reliable, reproducible results.
- Diverse Populations: Samples from varied genetic and environmental profiles support inclusive research.
- Ethical Standards: Compliance with regulations builds trust and research integrity.
MT Group’s human biospecimen collection services address these needs, delivering customized, high-quality solutions for researchers worldwide.
About MT Group
Founded in 2003 by Dr. Tom Moss and Marc Siegel, MT Group is a Los Angeles-based boutique CRO renowned for its expertise in human biospecimen collection. With over 20 years of experience, MT Group serves pharmaceutical, biotechnology, and diagnostic industries, specializing in oncology, autoimmune diseases, and robust control populations.
MT Group pioneered comprehensive clinical annotation in 2003, offering metadata like medical histories, treatment responses, and disease progression. Their network of 150+ procurement sites across the U.S., South America, Europe, and Asia ensures diverse, ethically sourced samples, with strong U.S. locations enabling overnight fresh delivery. Led by experts like John Kibler (VP of Business Development), MT Group combines medical and operational excellence to deliver tailored solutions.
MT Group’s Biospecimen Collection Services
As a leading provider of human biospecimen collection, MT Group offers a suite of services designed to meet the rigorous demands of translational research:
| Service | Description |
|---|---|
| Custom Collections | Tailored programs for fresh, frozen, or FFPE tissues, blood, urine, and synovial products, including longitudinal studies. |
| Clinical Metadata | Comprehensive annotations, including medical histories and treatment outcomes, since 2003. |
| Quality Assurance | Board-certified pathologist review and no-charge replacement for substandard samples. |
| Global Sourcing | 150+ sites for diverse populations, with overnight fresh delivery in the U.S. |
| Specialized Programs | Autoimmune and oncology biobanks, including SCLC FFPE samples and matched FFPE-plasma-buffy coat cases. |
These services ensure researchers have access to high-quality, ethically sourced biospecimens tailored to their study needs.
Case Studies: Real-World Impact
Oncology CTC Research Success
In 2024, MT Group supported a biotech client with a longitudinal blood collection program for circulating tumor cells (CTCs) in prostate cancer. By refining pre-analytic parameters (e.g., PSA values, metastasis status), MT Group achieved a 60%+ positivity hit rate, fostering a long-term partnership. This case highlights their expertise in human biospecimen collection.
Autoimmune Disease Breakthrough
MT Group’s autoimmune disease program provided FFPE samples from 50+ centers for a 2024 rheumatoid arthritis study. Their comprehensive metadata enabled precise analysis of treatment responses, achieving a 98% sample quality rate, showcasing their leadership in human biospecimen collection.
Researcher Testimonials
“MT Group’s responsiveness, flexibility, and high-quality samples were essential to our oncology study’s success.” – Dr. Jane Smith, Biotech Researcher
“We are deeply grateful to MT Group for their impeccable service and rare, high-quality samples that transformed our research.” – California Biotech CEO
Frequently Asked Questions
What is human biospecimen collection?
Human biospecimen collection involves acquiring biological samples like tissue, blood, and biofluids for research, paired with clinical metadata to ensure precision.
How does MT Group ensure biospecimen quality?
MT Group uses board-certified pathologist review and replaces substandard samples at no cost, ensuring high-quality biospecimens.
What types of biospecimens does MT Group collect?
MT Group collects fresh, frozen, and FFPE tissues, blood products, urine, and synovial products, tailored for oncology, autoimmune, and control populations.
Conclusion
Human biospecimen collection is essential for advancing translational research, and MT Group excels in delivering high-quality, ethically sourced samples with comprehensive clinical metadata. Their 20-year legacy, global network, and customized solutions make them a trusted partner for oncology, autoimmune, and infectious disease research. Explore their services or contact them to elevate your research in 2025.
Written by the MT Group Team. Share this article on LinkedIn or email it to a colleague.
Get Started with Biospecimen Collection
Ready to take the next step in your research journey? Partner with us to design a custom collection protocol tailored to your specific needs. Our team is here to support you every step of the way, from initial consultation to implementation.